New report shows 10% of UK’s top female BioBusiness talent is based at Stevenage Bioscience Catalyst

SBC biobusiness leaders feature in the Biobeat Movers and Shakers report

The report released today by BioBeat showcasing the 30 top female leaders in the UK bioscience sector has named three people from organisations based at Stevenage Bioscience Catalyst (SBC), totalling 10% of the list.

The three mentioned leaders based at SBC are Shree Patel from Achilles Therapeutics, Nicole Mathon from LifeArc and Bakul Gupta from ImmTune Therapies.

This is the seventh annual Movers and Shakers report released by BioBeat, and this year highlighted individuals pioneering scientists, financial experts, collaborators, innovators focused on impact on patients’ lives, and infrastructure specialists. This year’s Movers and Shakers also features alumni from previous reports, in which SBC is strongly represented, including CEO Dr Sally Ann Forsyth.

Shree Patel, Senior Vice President Global Clinical Operations at Achilles Therapeutics, said “I’m truly honoured to be included in this year’s Movers and Shakers report, and especially alongside so many pioneering women in our sector."

Nicole Mathon, Associate Director, Opportunity Assessment Group at LifeArc, said “The BioBeat Movers and Shakers report is always filled with such exceptional talent and I’m thrilled to be included in it."

Bakul Gupta, Co-Founder at ImmTune Therapies, said “As a new occupier at Stevenage Bioscience Catalyst, I am both elated to be mentioned in the BioBeat Movers and Shakers report this year, and looking forward to working alongside so many other talented women in the sector."

Dr Sally Ann Forsyth, CEO at SBC, commented “I am delighted that so many of our occupiers are included in the BioBeat report, and want to congratulate the winners on joining our long list of historic Movers and Shakers at SBC”.

See also: New report showcases resourceful leaders in UK bioscience for challenging times

About the BioBeat20 Summit

Time: 14:00-16:45, Tuesday 17th November 2020

Location: The Francis Crick Institute, London/Zoom videoconferencing

BioBeat20: Accelerating data-driven health is a half-day event for scientists, investors and entrepreneurs, discussing the tipping points for data-driven health adoption and investment. It’s an opportunity to explore what’s driving clinical and patient adoption of digital health technologies, examine the critical influences on investment and weigh-up how global trends are shaping companies.

The keynote lecture will be given by Samra Turajlic, Group Leader at the Francis Crick Institute and Consultant Medical Oncologist at the Royal Marsden Hospital, who will speak about the opportunities, challenges and practicalities of bringing data-driven healthcare to the clinic.

This year’s summit will be an online event. View the full programme and register to attend via Zoom for free at



Stevenage Bioscience Catalyst is a leading location for development and commercialisation of advanced therapeutics. The Campus is home to GSK, the Cell & Gene Therapy Manufacturing Catapult, LifeArc and Cytiva plus 40+ start-up companies which together have raised £1.8 bn equity investment, IPO/FPO, grants and acquisitions since 2012. The facilities provide business support, scientific equipment and scale up advice.

Stevenage Bioscience Catalyst